• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Ranbaxy Laboratories Ltd

+ Add to Watchlist

RLYG:GR

7.900 EUR 0.150 1.86%

As of 03:06:19 ET on 08/27/2014.

Snapshot for Ranbaxy Laboratories Ltd (RLYG)

Open: 7.877 Day's Range: 7.877 - 8.070 Volume: 316
Previous Close: 8.050 52wk Range: 3.012 - 8.070 1-Yr Rtn: +81.78%

Stock Chart for RLYG

No chart data available.
  • RLYG:GR 7.900
  • 1D
  • 1M
  • 1Y
8.050
Interactive RLYG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RLYG

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 3,349.71
Shares Outstanding (M) 424.01
30 Day Average Volume 2,073
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0391
Dividend Ex-Date 04/26/2011
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RLYG

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for RLYG

Ranbaxy Laboratories Limited manufactures and distributes a wide range of pharmaceutical products. The Company makes multisource antibiotics, analgesics, anti-inflammatory drugs and anti-ulcerant/gastrointestinal drugs such as "Roscillin" (Ampicillin), "Cifran" (Ciprofloxacin) and "Sporidex" (Cephalexin).

Arun SawhneyCEO/Managing DirectorIndrajit BanerjeePresident/CFO
Manjeet BindraChief Data Reliability OfficerRajiv GulatiPres:Global Pharmaceutical Bus
More Company Profile & Key Executives for RLYG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil